Highlights Hexima Limited

Equities

HXL

AU0000111932

Market Closed - Australian S.E. Other stock markets 06:56:47 09/05/2024 BST			5-day change	1st Jan Change
0.012 ^AUD	0.00%		+9.09%	-33.33%

03-22	Hexima Secures R&D Tax Rebate for Fiscal Year 2023	MT
03-19	Hexima Changes Address	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hexima Secures R&D Tax Rebate for Fiscal Year 2023	03-22	MT
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/02/23	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/08/22	CI
Hexima Limited Announces Phase II Results of Pezadeftide	10/07/22	CI
Hexima Limited Announces Preliminary Results of Phase II Clinical Study of Pezadeftide	24/06/22	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2021	23/02/22	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2021	27/08/21	CI
Hexima : Secures Chinese Patent for Fungal Nail Infection Treatment; Shares Surge 12%	24/08/21	MT
Hexima Limited Announces Design Patent for Pezadeftide Commercial Packaging	19/08/21	CI
Hexima Limited Announces Completion of Enrolment in Phase IIb Clinical Trial	26/07/21	CI
Hexima : Expects to Secure European Patent for Nail Fungal Infection Treatment	14/07/21	MT
Hexima Limited Extends Its Patent Protection for Pezadeftide	14/07/21	CI
Hexima : Secures Patent for Fungal Nail Infection Treatment	12/05/21	MT
Hexima Limited to Present Clinical Data from its Phase I/IIa Clinical Trial of HXP 124 for the Treatment of Onychomycosis at American Podiatric Medical Association Annual Conference	26/04/21	CI
Hexima Limited Announces Earnings Results for the Six Months Ended 31 December 2020	25/02/21	CI
Hexima Limited Updates Timeline to Phase 2B Results	07/01/21	CI
Hexima Limited has completed an IPO in the amount of AUD 3.280771 million.	30/11/20	CI
Hexima Limited Reports Earnings Results for the Year Ended June 30, 2019	29/11/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hexima Limited

Equities

HXL

AU0000111932

Highlights

Filters